Search

Your search keyword '"C. Albers"' showing total 760 results

Search Constraints

Start Over You searched for: Author "C. Albers" Remove constraint Author: "C. Albers"
760 results on '"C. Albers"'

Search Results

5. Taking a Breath of the Wild: are geoscientists more effective than non-geoscientists in determining whether video game world landscapes are realistic?

6. Flooded by jargon: how the interpretation of water-related terms differs between hydrology experts and the general audience

7. Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases

8. LUNG FUNCTION RESPONSE TO ALBUTEROL-BUDESONIDE VERSUS ALBUTEROL WHEN USED REPETITIVELY OVER 1 AND 4 WEEKS: RESULTS FROM THE DENALI STUDY

9. Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

10. Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma

11. Supplemental Table 2 from The Cyclic AMP Pathway Is a Sex-Specific Modifier of Glioma Risk in Type I Neurofibromatosis Patients

12. Supplemental Table 3 from The Cyclic AMP Pathway Is a Sex-Specific Modifier of Glioma Risk in Type I Neurofibromatosis Patients

13. Supplemental Table 1 from The Cyclic AMP Pathway Is a Sex-Specific Modifier of Glioma Risk in Type I Neurofibromatosis Patients

15. Mepolizumab improves work productivity, activity limitation, symptoms, and rescue medication use in severe eosinophilic asthma

16. Single-Day Low-Residue Diet Prior to Colonoscopy Demonstrates Improved Bowel Preparation Quality and Patient Tolerance over Clear Liquid Diet: A Randomized, Single-Blinded, Dual-Center Trial

17. Impact of baseline clinical asthma characteristics on the response to mepolizumab: a post hoc meta-analysis of two Phase III trials

18. LUNG FUNCTION RESPONSE TO ALBUTEROL-BUDESONIDE VERSUS ALBUTEROL WHEN USED REPETITIVELY OVER 1 AND 4 WEEKS: RESULTS FROM THE DENALI STUDY

19. Brown Bowel Syndrome Is a Rare and Commonly Missed Disease: A Case Report and Literature Review

20. Efficacy and safety of mepolizumab in Korean patients with severe eosinophilic asthma from the DREAM and MENSA studies

21. Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma

22. Response to mepolizumab treatment is sustained across 4-weekly dosing periods

23. Oral IBGard™ Before Colonoscopy: A Single-Center Double-Blinded, Randomized, Placebo-Controlled Trial

24. Parameter sensitivity analysis of a two-dimensional cryo-hydrogeological numerical model of degrading permafrost near Umiujaq (Nunavik, Canada)

25. Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracy

26. Dipolar effects on the work function of an alkali-iodide overlayer (XI, X = Li, Na, K, Rb, and Cs) on tungsten surfaces

28. Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study

29. Severe eosinophilic asthma with nasal polyposis: A phenotype for improved sinonasal and asthma outcomes with mepolizumab therapy

30. Die emotionale Kompetenz der Mutter und die klinische Qualität der Mutter-Kind-Beziehung in einer vorschulpsychiatrischen Inanspruchnahmepopulation

31. Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use

32. The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

33. Impact of exacerbations on St George’s Respiratory Questionnaire score in patients with severe asthma: post hoc analyses of two clinical trials and an observational study

34. Clinical burden of illness among patients with severe eosinophilic COPD

35. Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracy

36. Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics

38. Visualization formats of Patient-Reported Outcomes in clinical practice: a systematic review about preferences and interpretation accuracy. (Preprint)

39. Efficacy and safety of as-needed albuterol/budesonide versus albuterol in adults and children aged ≥4 years with moderate-to-severe asthma: rationale and design of the randomised, double-blind, active-controlled MANDALA study

40. Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes

41. Electronic correlation induced expansion of Fermi pockets inδ-plutonium

42. Clinical effects of mepolizumab in patients with severe eosinophilic asthma according to background therapy: A meta-analysis

43. The Wick Sign After Cold Snare Polypectomy: A Case Report

44. Long-term safety and durability of mepolizumab in life-threatening/seriously debilitating severe eosinophilic asthma (SEA): COSMEX

46. Author response for 'Incidence, risk factors and re‐exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study'

47. Rapid and Consistent Improvements in Morning PEF in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab

49. Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma

50. Biologic treatment eligibility for real-world patients with severe asthma: The IDEAL study

Catalog

Books, media, physical & digital resources